TW201613934A - Methods for the preparation of 1,3-benzodioxole heterocyclic compounds - Google Patents

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Info

Publication number
TW201613934A
TW201613934A TW104120096A TW104120096A TW201613934A TW 201613934 A TW201613934 A TW 201613934A TW 104120096 A TW104120096 A TW 104120096A TW 104120096 A TW104120096 A TW 104120096A TW 201613934 A TW201613934 A TW 201613934A
Authority
TW
Taiwan
Prior art keywords
preparation
heterocyclic compounds
methods
benzodioxole
benzodioxole heterocyclic
Prior art date
Application number
TW104120096A
Other languages
English (en)
Chinese (zh)
Inventor
Bjoern Metzler
Andre Faldt
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of TW201613934A publication Critical patent/TW201613934A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW104120096A 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds TW201613934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14173397 2014-06-23

Publications (1)

Publication Number Publication Date
TW201613934A true TW201613934A (en) 2016-04-16

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104120096A TW201613934A (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Country Status (18)

Country Link
US (1) US9908894B2 (enExample)
EP (1) EP3157930B1 (enExample)
JP (1) JP6785666B2 (enExample)
KR (1) KR20170016894A (enExample)
CN (1) CN106459081B (enExample)
AU (1) AU2015279428B2 (enExample)
BR (1) BR112016029510A2 (enExample)
CA (1) CA2953284A1 (enExample)
DK (1) DK3157930T3 (enExample)
ES (1) ES2702451T3 (enExample)
IL (1) IL249336A0 (enExample)
MX (1) MX2016016378A (enExample)
PL (1) PL3157930T3 (enExample)
PT (1) PT3157930T (enExample)
RU (1) RU2697251C2 (enExample)
TW (1) TW201613934A (enExample)
WO (1) WO2015197534A2 (enExample)
ZA (1) ZA201608442B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI774791B (zh) * 2017-06-20 2022-08-21 丹麥商聯合醫療公司 1,3-苯并二氧雜環戊烯雜環化合物之製備方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3390407T3 (da) 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
WO2019115776A1 (en) 2017-12-15 2019-06-20 Leo Pharma A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
KR20210117300A (ko) 2019-01-15 2021-09-28 유니온 테라퓨틱스 에이/에스 포스포디에스테라제 억제제를 함유하는 변형 방출 정제 제형
KR20230159485A (ko) 2021-03-22 2023-11-21 유니온 테라퓨틱스 에이/에스 오리스밀라스트를 사용한 화농땀샘염의 치료
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1000785A1 (en) * 1995-05-19 2006-06-30 Kyowa Hakko Kogyo Co., Ltd Oxygen-containing heterocyclic compounds
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
AU2003252467A1 (en) * 2002-07-03 2004-01-23 Kyowa Hakko Kogyo Co., Ltd. Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
DE602007012105D1 (de) * 2006-07-14 2011-03-03 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
US8148537B2 (en) 2006-12-22 2012-04-03 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
ZA200905371B (en) * 2007-02-28 2010-10-27 Leo Pharma As Novel phosphodiesterase Inhibitors
JP6174997B2 (ja) * 2010-06-24 2017-08-02 レオ ファーマ アクティーゼルスカブ ホスホジエステラーゼ阻害剤としてのベンゾジオキソールまたはベンゾジオキセピンヘテロ環化合物
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
DK3390407T3 (da) * 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI774791B (zh) * 2017-06-20 2022-08-21 丹麥商聯合醫療公司 1,3-苯并二氧雜環戊烯雜環化合物之製備方法

Also Published As

Publication number Publication date
CN106459081B (zh) 2019-09-10
AU2015279428B2 (en) 2018-02-15
US20170137438A1 (en) 2017-05-18
WO2015197534A3 (en) 2016-03-17
ES2702451T3 (es) 2019-03-01
PT3157930T (pt) 2018-12-24
IL249336A0 (en) 2017-02-28
EP3157930B1 (en) 2018-10-17
ZA201608442B (en) 2018-05-30
RU2017101808A3 (enExample) 2019-01-22
JP6785666B2 (ja) 2020-11-18
CA2953284A1 (en) 2015-12-30
JP2017520547A (ja) 2017-07-27
DK3157930T3 (en) 2019-01-21
WO2015197534A2 (en) 2015-12-30
EP3157930A2 (en) 2017-04-26
MX2016016378A (es) 2017-10-16
RU2697251C2 (ru) 2019-08-13
US9908894B2 (en) 2018-03-06
RU2017101808A (ru) 2018-07-27
BR112016029510A2 (pt) 2017-08-22
PL3157930T3 (pl) 2019-04-30
KR20170016894A (ko) 2017-02-14
CN106459081A (zh) 2017-02-22
AU2015279428A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
PH12018500718A1 (en) Compounds useful as modulators of trpm8
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
EA201792535A1 (ru) Гетероциклические амиды в качестве ингибиторов киназ
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
PH12016501941A1 (en) Use of heterocyclic compounds for controlling nematodes
HK1245019A1 (zh) 吡啶酰胺化合物作爲杀真菌剂的用途
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12018500408A1 (en) Bicyclic compounds as atx inhibitors
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
MX2018001890A (es) Compuestos biciclicos como inhibidores de autotaxina (atx).
MX2016016378A (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
MX2017008442A (es) Uso de picolinamidas como fungicidas.
PH12018500409A1 (en) New bicyclic compounds as dual atx/ca inhibitors
NZ742952A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
EA202091397A1 (ru) Бензохинолоновые ингибиторы vmat2
MX394835B (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
MX373320B (es) Compuestos inhibidores de pde2.
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
PH12016501613B1 (en) Pyrazines modulators of gpr6
AU2015311730A8 (en) CaMKII inhibitors and uses thereof
MA39824A (fr) Composés azole amido-substitués
IN2015CH01182A (enExample)
BR112016027455A2 (pt) moduladores ppar
MX371158B (es) Compuestos inhibidores de pde2.